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ABSTRACT 
Objective: We assessed the acute effect of beetroot extract intake on cardiovascular and 
autonomic recovery subsequent to strength exercise. Methods: This is a crossover, 
randomized, double-blind and placebo-controlled trial. We assessed 16 subjects but only 
12 healthy male adults completed the two protocols in two randomized days: Beetroot 
extract (600 mg in capsule) and placebo (600 mg starch in capsule). Beetroot extract or 
placebo was ingested, the subjects endured 120 minutes seated at rest, followed by a 75% 
1RM strength exercise and then remained seated for 60 minutes at rest. Cardiorespiratory 
parameters, heart rate (HR) variability (HRV) (SDNN, rMSSD, pNN50, SD1, SD2 HF 
[ms2]) were estimated before, during exercise and during recovery from exercise. 
Results: ingestion of beetroot extract before exercise: accelerates the recovery of SBP 
following physical effort; improves HR recovery to baseline resting levels (beetroot 
protocol: change in ~62% vs. placebo protocol: change in ~80%), and intensifies the 
return of vagal HR control during recovery after exercise. Conclusions: Beetroot extract 
acutely improved cardiovascular and autonomic recovery after exercise.  
Keywords: Beta vulgaris L.; Dietary Supplements; Exercise; Autonomic Nervous 
System; Cardiovascular system. 
INTRODUCTION 
 Beetroot (Beta vulgaris L.) is amongst the six ergogenic supplements suggested 
by the Australian Sports Institute that can be prescribed to optimize performance during 
exercise (1). The most frequently applied form of pre-workout is its juice (1). The 
explanation for its application in this format is due to the need for nitrate (N03−) to be 
partially reduced to nitrite (NO2-) by oral bacteria via the enzyme N03− reductase and 
when it reaches the stomach to be reduced once more and transformed into nitric oxide 
(NO) and, hence, increase NO concentrations in the blood (2). This mechanism results in 
an intensification in respiratory capacity and oxygen consumption (VO2max) during 
physical exercise (3).  
Moreover, further studies have been undertaken with the objective of instigating 
the use of beet and its contributions to cardiovascular parameters. The main advantages 
established thus far are a reduction in heart rate (HR) and blood pressure (BP), also 
inducing vasodilation (3,4).  
 In this manner, up until now something may not have been fully explained, 
considering that in addition to nitrate, beets have antioxidant substances such as 
flavonoids, anthocyanins and betaine, and all have cardioprotective properties (5,6). 
Yet, betaine also effective in reducing levels of homocysteine, an amino acid 
resultant from renal metabolism and when raised in the blood it develops into a risk factor 
for cardiovascular and neurodegenerative diseases (7). In addition, other fruit juices rich 
in polyphenols (e.g. Chokeberry, Cherry, Noni) have been revealed to be effective in 
promoting cardioprotective responses (e.g. Lowering blood glucose, Fibrinogen, LDL 
cholesterol and increasing HDL cholesterol) (8-10). 
In this context, a more detailed analysis of the compounds contributions of the 
beetroot extract to cardiovascular and neural activity in normal and pathological 
conditions is obligatory (5). Latterly, the activity of the cardiovascular parameters of HR 
and BP has been examined in conjunction with the activity of the autonomic nervous 
system (ANS). Thus, HR variability (HRV) is considered a practical way of assessing 
ANS in many situations. HRV evaluates the oscillations between inter-beat cardiac 
intervals (IBI) and scrutinizes the control of the ANS over heart rhythm (11-16). 
Likewise, HRV has been enforced to assess the effect of certain conditions or 
interventions on the autonomic and cardiovascular functions on physical exertion (17). 
The introduction of physical effort and the scrutiny of recovery after cessation of 
exercise have been understood in clinical studies and applied so as to verify the autonomic 
adaptations to the intervention (18). There is a close association between improved post 
exercise autonomic recovery and cardiovascular benefits. The research literature has 
provided consistent data that after stress tests, individuals who presented attenuated 
parasympathetic reactivation have higher cardiovascular risk (17,19,20). This is because 
of the reduction in autonomic efficiency in adapting to the overlapping condition and is 
present in many situations that have a high relationship with cardiovascular complications 
(e.g. acute myocardial infarction, high blood pressure, obesity, diabetes and cancer) (21). 
With this in mind, a prolonged delay in the recovery of HRV indices have been 
related to the enlarged risk of cardiovascular death and, in contrast, optimization of HRV 
recovery is related to an effective autonomic adaptation (19). 
In light of the above considerations, we highlight the following: Is beetroot extract 
capable of improving cardiovascular recovery after exercise? In an optimistic case, is it 
by reason of the advantageous effects on the autonomic nervous system? We highlight 
the aforesaid questions so as to elucidate whether beetroot is a safe supplement for athletic 
performance. With the resolve to answer these questions, we evaluated the acute effects 
of beetroot extract on autonomic and cardiovascular recovery after strength exercises. 
 
METHOD 
This study followed the CONSORT (Consolidated Standards of Reporting Trials) 
statement. This is a crossover, randomized, double-blind and placebo-controlled trial 
(Protocol number NCT04094233, https://clinicaltrials.gov/ct2/show/NCT04094233, 
Research Ethics Committee in Research Approval Number 3.383.454). 
Participants 
At first, we evaluated 16 healthy college educated males, physically active and with 
greater than six months experience of strength exercises without interruption (minimum 
3 sessions per week). 12 males completed the protocols. We excluded subjects with 
resting systolic BP (SBP)>130 mmHg, resting HR>100 bpm, body mass index 
(BMI)<18.5 kg/m2 and BMI >29.9 kg/m2, body fat >5th percentile, those who took 
anabolic steroids and subjects who were unable to complete all the necessary stages of 
the experimental protocol (Figure 1).  
Subjects were excluded under the following conditions: cardiorespiratory, 
neurological, musculoskeletal, renal, metabolic, endocrine and other reported medical 
disorders that prohibited the successful completion of the protocols. Those subjects 
undergoing pharmacotherapies, smokers, and those who presented a resting root mean 
square of successive differences (RMSSD) index <15ms were also excluded (15).   
Initial Assessment 
The subjects were recognized by assembling data such as age (years), mass (kg), 
height (cm), heart rate (beats per-minute), systolic blood pressure (SBP) and diastolic 
blood pressure (DBP) (mmHg), BMI (kg/m²) and Body Fat (%). Levels of physical 
activity for the subjects were evaluated by the enforcing the International Physical 
Activity Questionnaire (IPAQ) (22). 
The anthropometric measurements were completed through the agreements 
described previously (23, 24). The estimated fat percentage was determined via the 
mathematical formula from Siri et al. 1961. (25) 
Outcomes 
Cardiorespiratory variables: 
During the SBP and DBP measurements, the subjects remained seated. SBP and 
DBP were obtained indirectly by auscultation with a stethoscope (Littman Classic II, St. 
Paul, USA) and, a calibrated aneroid sphygmomanometer (Welch Allyn Tycos, New 
York, USA) on the subjects’ left arm. The HR was calculated via the Polar RS800cx HR 
monitor (Polar Electro, Finland).  
HRV Analysis: 
HRV analysis was completed according to the Task Force of the European Society 
of Cardiology and the North American Society of Pacing and Electrophysiology 
guidelines. The HR was reached beat-to-beat during the procedures via a HR monitor 
(Polar RS800cx, Finland).  Further details have been described before (26-28). 
The time domain index of HRV was studied by the root mean square of successive 
differences (RMSSD), the percentage of adjacent IBI with a difference of duration greater 
than 50ms (pNN50), the frequency domain index was evaluated via the high frequency 
spectral component (HF) of the power spectral density (0.15 to 0.4 Hz) in absolute units; 
the quantifiable Poincaré plot analysis was achieved through the SD1 (standard deviation 
of the instantaneous beat-to-beat variability) and SD2 (standard deviation of long-term 
continuous beat-to-beat variability indices). For data analysis we selected a stable series 
of 256 consecutive IBIs (15).  
We decided not to estimate the low frequency (LF) or the LF/HF ratio since they 
have been shown to be theoretically flawed and empirically unfounded to accurately 
represent the sympatho-vagal balance (29). 
To compute the HRV indices we used the Kubios HRV software package (Kubios® 
HRV version1.1, University of Kuopio, Finland) (30). 
Interventions 
The experimental procedure was divided into three stages, with a minimum 
interval of 48 to 72 hours between them, to permit adequate recovery of the participants. 
The study was performed between 18:00 and 21:00 to standardize circadian effects 
(31), in a noiseless room with humidity between 55% and 70% and temperature between 
22°C and 25°C. The subjects were instructed to abstain from drinking alcohol or 
performing exhaustive exercise 24 hours prior to each protocol and to avoid ingesting 
caffeinated beverages or foodstuffs 24 hours before the experimental procedures. 
Subjects were advised to dress in suitable and comfortable clothing to allow the required 
physical effort and to only eat a light meal two hours in advance of the procedures. 
As an initial phase of the protocols, the subjects were told to consume a beetroot 
extract (600mg capsule) or starch (600mg placebo capsule) 120 minutes before the 
procedure; to permit a suitable time for digestion, absorption and display its physiological 
effects (3). 
The beet extract was obtained in its commercial form. According to producer 
(Florien®, Brazil) information, the active part was derived from its root. Its chemical 
composition was composed of: Dry extract (10%) standardized in 10% betaine and 2.5% 
nitrate. Sugars: sucrose (15-20%), fructose and glucose; Mineral salts: potassium, 
sodium, calcium, magnesium, iron (in small amounts); Vitamins: A, B1, B2 and C; 
Fibers; Glutamine; Pigments: betanidine, collima and betaine; Volatile Substances: 
pyridine; Rafanol; Saponins; Alkaloid: betalain; Flavonoids: isoramnetina).  
The capsules were visibly identical so that neither the researcher nor the subject 
could identify the contents of the capsules. The same person was accountable for selection 
of the capsules and allocating them to the researchers. 
Later, the intensity of physical exercise was determined based on the 1 repetition 
maximum test (1RM), which defined the training load for the subsequent steps. The test 
was performed according to the American College of Sports Medicine Recommendations 
for Exercise Testing and Prescription. Study participants were trained to test the load 
using the following exercises: Leg Press 45º, Extender Chair, Abductor Chair, and Squat. 
In the following steps, data collection was achieved under the beetroot extract or placebo 
protocol and the exercise was completed based on 75% of 1RM (10 max. repetitions) 
distributed through four sets for each exercise (Figure 2). The exercise sequence tracked 
the following sequence: 
1) Leg Press 45º;  
2) Extender Chair;  
3) Abductor Chair; 
4) Squat. 
Experimental Protocols: 
HR, SBP and DBP were measured at the ensuing moments: Rest – 120th to 125th 
minute after capsule ingestion – and during recovery - 1st, 2nd, 3rd, 5th, 7th, 10th, 20th, 30th, 
40th, 50th and 60th minutes after exercise. 
The HRV indexes were considered at the following epochs: Rest (R1: 120th to 
125th minute of resting after capsule ingestion), exercise (Exercise: during the last 
exercise, the squat) and during recovery: Rec1 (5th to 10th minute), Rec2 (15th to 20th 
minute), Rec3 (25th to 30th minute), Rec4 (35th to 40th minute), Rec5 (45th to 50th minute), 
Rec (55th to 60th minute). 
Sample Size 
 The sample calculation was accomplished by a pilot study performed in 5 subjects. 
We applied the online software from the website www.lee.dante.br, which provided the 
magnitude of the difference and we calculated the RMSSD index as a reference. We 
measured a standard deviation of 12.8ms and the magnitude of the difference was 
14.11ms. The sample size provided was a minimum of 11 subjects per group, with alpha 
risk of 5% and beta risk of 80%. 
Statistical analysis 
Data normality was evaluated by the Shapiro-Wilk statistical test (32). We followed 
approaches for HRV experiment planning, data analysis, and data reporting as discussed 
by Laborde et al. (32). To compare cardiovascular variables and HRV, we calculated 
repeated measures one-way analysis of variance (ANOVA) followed by the Bonferroni 
post-test for parametric distributions or, Friedman followed by the Dunn’s post-test for 
non-parametric distributions (32). 
Effect sizes were calculated by Cohen's d to measure the magnitude of changes for 




The sample description regarding age, mass, height, BMI and body fat of the 12 
subjects are designated in Table 1. Table 1 illustrates the homogeneity within the group 
for the offered variables. 
HR, SBP and DBP during recovery from exercise 
We detected significant changes for SBP between rest and recovery in placebo and 
beetroot extract protocols. Concerning the placebo protocol, SBP was increased at 1 
minute after exercise vs. rest (Cohen’s d=2.88) and it likewise increased at 3 minutes after 
exercise vs. rest (Cohen’s d=1.39). In the beetroot extract protocol, SBP increased 1 
minute after exercise vs. rest (Cohen’s d=1.49) (Figure 3A). 
With regards to DBP, we detected no alteration between rest and recovery from 
exercise in placebo and beetroot extract protocols (Figure 3B).  
Concerning HR in the placebo protocol, we noticed an increase during exercise vs. 
rest (Cohen’s d=4.92) and remained higher from 1 to 20 minutes during recovery from 
exercise vs. rest (1 min: Cohen’s d=3.31; 3 min: Cohen’s d=2; 5min: Cohen’s d=1.59; 7 
min: Cohen’s d=1.47; 10 min: Cohen’s d=1.37; 20 min: Cohen’s d=1.08). In the beetroot 
extract protocol, HR enlarged during exercise vs. rest (Cohen’s d=3.96) and was higher 
from 1 to 10 minutes following exercise (1 min: Cohen’s d=2.9; 3 min: Cohen’s d=1.9; 5 
min: Cohen’s d=1.66; 7 min: Cohen’s d=1.33; 10 min: Cohen’s d=1.43) (Figure 3C). 
 
HRV during exercise and following effort 
During the placebo protocol, SDNN was reduced during exercise vs. rest (Cohen’s 
d=1.8) and it decreased 5-50 minutes following exercise end vs. rest (5-10 min: Cohen’s 
d=2.02; 15-20 min: Cohen’s d=1.55; 25-30 min: Cohen’s d=1.31; 35-40 min: Cohen’s 
d=1.02; 45-50 min: Cohen’s d=0.77). In the beetroot extract protocol, SDNN was lower 
during exercise vs. rest (Cohen’s d=1.19) and it reduced 5-30 minutes after exercise vs. 
rest (5-10 min: Cohen’s d=1.85; 15-20 min: Cohen’s d=1.43; 25-30 min: Cohen’s d=1.27) 
(Figure 4). 
We detected that in the placebo protocol that RMSSD was lessened during exercise 
vs. rest (Cohen’s d=1.88) and it reduced 15-50 minutes vs. rest (5-10 min: Cohen’s d 
=1.56; 15-20 min: Cohen’s d=1.29; 25-30 min: Cohen’s d=1.1; 35-40 min: Cohen’s 
d=0.89; 45-50 min: Cohen’s d=0.63). In the beetroot extract protocol, RMSSD was lesser 
during exercise vs. rest (Cohen’s d=1.27) and it declined 5-30 minutes following exercise 
vs. rest (5-10 min: Cohen’s d=0.95; 15-20 min: Cohen’s d=0.8; 25-30 min: Cohen’s 
d=0.71) (Figure 4). 
With regards the pNN50 in the placebo protocol, it reduced during exercise vs. rest 
(Cohen’s d=1.4) and it was lower 5-60 minutes after exercise vs. rest (5-10 min: Cohen’s 
d=1.29; 15-20 min: Cohen’s d=1.14; 25-30 min: Cohen’s d=1.06; 35-40 min: Cohen’s 
d=0.8; 45-50 min: Cohen’s d=0.56; 55-60 min: Cohen’s d=0.52). The identical index for 
the beetroot extract protocol was reduced during exercise vs. rest (Cohen’s d=1.17) and 
it decreased 5-30 minutes following exercise cessation (5-10 min: Cohen’s d=0.87; 15-
20 min: Cohen’s d=0.84; 25-30 min: Cohen’s d=0.77) (Figure 4). 
In the placebo protocol, SD1 declined during exercise vs. rest (Cohen’s d=1.88) and 
it declined 5-50 minutes after effort vs. rest (5-10 min: Cohen’s d=1.56; 15-20 min: 
Cohen’s d=1.27; 25-30 min: Cohen’s d=1.1; 35-40 min: Cohen’s d=0.89; 45-50 min: 
Cohen’s d=0.63). In the beetroot extract protocol, SD1 lessened during exercise vs. rest 
(Cohen’s d=1.3) and it was lower 5-30 minutes following exercise cessation vs. rest (5-
10 min: Cohen’s d=0.97; 15-20 min: Cohen’s d=0.82; 25-30 min: Cohen’s d=0.72) 
(Figure 5). 
Concerning SD2 in the placebo protocol, it declined during exercise vs. rest 
(Cohen’s d=1.77) and it reduced 5-50 minutes after effort vs. rest (5-10 min: Cohen’s 
d=0.26; 15-20 min: Cohen’s d=1.55; 25-30 min: Cohen’s d=1.32; 35-40 min: Cohen’s 
d=1.02; 45-50 min: Cohen’s d=0.91). In the beetroot extract protocol, SD2 lessened 
during exercise vs. rest (Cohen’s d=1.16) and it decreased 5-30 minutes after exercise end 
vs. rest (5-10 min: Cohen’s d=2.14; 15-20 min: Cohen’s d=1.61; 25-30 min: Cohen’s 
d=1.4) (Figure 5). 
In relation to HF (ms2) in the placebo protocol, it lessened during exercise vs. rest 
(Cohen’s d=1.09) and it reduced 5-60 minutes following effort vs. rest (5-10 min: 
Cohen’s d=1.05; 15-20 min: Cohen’s d=0.84; 25-30 min: Cohen’s d=0.85; 35-40 min: 
Cohen’s d=0.69; 45-50 min: Cohen’s d=0.53; 55-60 min: Cohen’s d=0.54). In the 
beetroot extract protocol, HF (ms2) declined during exercise vs. rest (Cohen’s d=0.8) and 
it deteriorated 5-30 minutes following exercise vs. rest (5-10 min: Cohen’s d=0.75; 15-
20 min: Cohen’s d=0.67; 25-30 min: Cohen’s d=0.63) (Figure 5). 
 
DISCUSSION 
Our findings endorse that ingestion of beetroot extract before exercise: (a) 
accelerates the recovery of SBP following physical effort; (b) improves HR recovery to 
baseline resting levels (beetroot protocol: change in ~62% vs. placebo protocol: change 
in ~80%). and (c) intensifies the return of vagal HR control during recovery after exercise. 
No significant deviations were acknowledged for DBP (beetroot protocol: change in ~7% 
vs. placebo protocol: change in ~6%). 
Observations on the physiological effects of beetroot juice have specified the 
possibility of a new perspective on its use, being useful not only in athletes, but as a 
supporting strategy in the treatment of associated cardiovascular system pathologies (4). 
Previous evidence has demonstrated that these results are similar in both young and 
adult populations (34) estimating the concentrations of NO2- and NO3- in the young 
persons’ plasma (25 ± 3 years) and older adults (56 ± 6 years) after ingesting 150ml of 
beetroot juice. The study confirmed that there is a significant increase of NO2- and NO3- 
in both groups after 2.5 hours and 3.25 hours compared to placebo (p<0.0001). In the 
same study, it was conveyed that a decrease in SBP values in both age groups after 
beetroot juice ingestion, whereas the reduction in DBP was only achieved in older adults 
(p<0.005). 
Concerning this, a further study has demonstrated that beetroot juice significantly 
reduced SBP at rest and throughout exercise (40% and 80% of VO2max) in healthy 
women (35). 
Whilst our results have the same indications for SBP (beetroot protocol: change in 
~8% vs. placebo protocol: change in ~15%), we disapprove of further detailed studies on 
the effects of beetroot compounds, in addition to nitrate. Yet, the effects of the antioxidant 
substances of beetroot may have been unnoticed, since the studies only measured nitrate 
concentrations. In this case, we assessed the application of beetroot extract involving 
600mg containing 10% dry extract, 10% betaine and 5% nitrate. Also, we emphasize that 
an innovative search in the format (e.g. capsules, pills etc.) for its administration would 
be useful, since the flavor of beetroot juice is not always bearable. 
Incidentally, our results identified that when ingesting beetroot extract, the SBP 
recovery after physical effort is optimized when related to the placebo protocol. Whereas 
the recovery of SBP in the beetroot extract protocol takes place in the 3rd min, in the 
placebo protocol it is only visible in the 5th min after physical exercise. It reinforces the 
beneficial effects of beetroot extract on cardiovascular function. We noticed no changes 
in the recovery of DBP between the two protocols.  
The study conducted by Perez et al. (36) presented controversial results. The authors 
confirmed that the consumption of beet juice (7 days x 500ml serving with a concentration 
of approximately 5.2 mmol of nitrate) did not change VO2max (Beet: 51.07 ± 6.12 vs 
Placebo: 50.46 ± 6.06), SBP (Beet: 180.65 ± 23.37 vs Placebo: 177.65 ± 22.07) and DBP 
(Beet: 92.90 ± 18.89 vs Placebo: 90.75 ± 17.73) during submaximal aerobic exercise 
when compared to the placebo group. 
Whereas according to our results, we documented that the HR response displayed 
promising results, considering that its recovery was further accelerated during the 
beetroot extract intervention. The HR of the beetroot extract protocol recovered during 
the 20 min after termination of exercise, whilst the intervention with placebo at that time 
was not yet fully recovered. These effects on the HR response is conceivably due to the 
increase of parasympathetic activity and autonomic activity optimization (30). 
In addition to beetroot, quite a few other juices from fruits rich in polyphenols have 
had their effects investigated on cardiovascular responses. In general, positive changes 
are demonstrated when there is both acute (8) and continuous (10) administration. 
Amongst these compounds, the intake of 30ml of Noni juice was able to 
significantly decrease HR (77.4 ± 9.0 to 71.6 ± 8.1) (p= 0.03), SBP (5%) (p=0.024) and 
DBP (7.5%) (p=0.006) after 3 hours of administration. Moreover, its use can be 
investigated in hyperglycemic populations, since it caused a 7.3% reduction in blood 
glucose levels (8). 
In this way, the administration of 300ml Cherry juice rich in anthocyanins is able 
to reduce HR, SBP and DBP. The effects of Cherry juice are immediate, considering that 
despite significantly reducing HR, SBP and DBP after 2 hours following ingestion 
(p<0.05), these same effects were not achieved after 6 hours of administration (9). 
Skoczynska et al. (10) demonstrated that regular consumption for six weeks of 
Chokeberry juice (250ml/day) was able to significantly decrease LDL cholesterol, 
triglycerides, homocysteine levels and blood pressure in men with hypercholesterolemia. 
Also, it was responsible for an increase in HDL cholesterol levels. 
Energy drinks containing the combination of 2-aminoethanesulfonic acid (taurine) 
and caffeine, seemingly do not have noticeable effects on the cardiovascular system, 
because of the antiarrhythmic effects of taurine (38). Yet, there are disagreements in the 
research literature and some studies, such as Nelson et al. (39), which described an 
increase in HR (Energy Drink (ED): 65 ± 10 bpm vs Placebo: 58 ± 8 bpm, p=0.02) after 
exhaustion exercise in combination with ED (caffeine: 2mg.kg/body and taurine: 
25mg.kg/body). Yet, in the same study, no changes were observed regarding the HRV 
parameters.  
Alternatively, it is recognized that the use of caffeine alone promotes a delay in the 
return of parasympathetic activity to baseline levels following physical effort (14, 40-41). 
Even if studies signifying the connection between beetroot and autonomic nervous 
system activity are rare, two studies determined that beetroot juice has positive effects on 
ANS activity. Notay et al. (37) established that the application of 70ml of nitrate-rich 
beetroot juice (~6.4mmol NO3-) 165 to 180 minutes before exercise is capable of 
decreasing sympathetic activity before and during physical activity (37). 
These similar results were identified by Bond et al. (35), in which the application 
of 70ml of beetroot juice (~ 400mg NO3-) produced increased HRV as quantified by 
SDNN, before and during physical activity with an intensity of 40% and 80% of VO2max 
(35). 
In agreement with these studies, our results authenticate that beetroot extract 
improves HRV during exercise and after recovery. It is possible to distinguish this 
through SDNN, HF and RMSSD indices, which indicate a rapid vagal nerve activation in 
the post-exercise period. These indexes had an improved recovery in the beetroot extract 
protocol versus the placebo. 
Also, the improvement in HRV is justifiable, considering the higher values of 
pNN50 in the beetroot extract protocol. Similarly, after 60 minutes of data recording, in 
the placebo protocol, pNN50 did not fully recover. 
Furthermore, the geometric HRV indices (SD1 and SD2) approve the equivalent 
results. This is by reason that the recovery of these indices in the beetroot extract protocol 
was quicker, between 30 and 35 min following physical exercise, but during the placebo 
protocol these indices only recovered completely between 50 and 55 min. 
In this manner, it is likely to observe that the influence of beetroot extract on 
autonomic activity is beneficial, assuming that there is an optimization in recovery after 
exercise. This effect is considered to accomplish an improved efficiency of the autonomic 
regulation during cardiac activity. 
Similarly, the antioxidant profile of beetroot extract protocol could be involved in 
the faster autonomic recovery after exercise (42). During physical effort, blood pressure 
and HR modulation are transformed, baroreflex sensitivity is lessened at brainstem level 
in response to metaboreflex activation. Elevated cellular metabolism leads to metabolic 
accumulation and activates metaboreceptors. Consequently, non-myelinated afferent 
fiber stimulation elevates sympathetic activity, triggering increased HR, cardiac output, 
blood pressure and vasoconstriction in non-active muscles. After exercise, progressive 
removal of metabolites during effort recovery decreases metaboreflex activation, 
restoring baroreflex activity (43). We hypothesize that beetroot extract protocol 
accelerates metabolic removal because of its antioxidant effects (42). 
Some points need highlighting. Even though our study population is small, it 
surpassed that suggested by sample calculation value. Principally, we emphasize that the 
outcomes were statistically significant and make these results promising as they provide 
relevant information about the usage of beetroot supplement before physical exercise. 
Similarly, the effect size calculation by Cohen’s d reinforced our statistical outcomes. 
We declined assessment of the low frequency index (LF) and the LF/HF ratio, since 
the research literature reveals that its concept is defective and lacks empirical support to 
characterize the sympathetic-vagal balance (29). 
We decided to evaluate only healthy and physically active individuals due to ethical 
reasons and avoid possible complications in subjects with cardiovascular or metabolic 
risks. Physically active individuals presented a trivial probability of health complications. 
We highlight that further studies using larger populations are needed to give greater 
certainty to the results found. We emphasize the importance of new studies determining 
the amount of bioactive compounds present in the capsules to better ascertain which 
components are responsible for the physiological effects. 
Since this is a novel study, we emphasize the requirement to develop other studies 
in order to test beetroot extract in other cohorts, with different ages and genders, as the 
results achieved cannot be generalized.  
Thus, we encourage further studies to explore the effects on people with 
cardiovascular or metabolic disorders, in an attempt to find preventative approaches and 
to minimize the risk of likely health difficulties. 
Our results provide introductory data supportive of the use of beetroot extract prior 
to strength exercise. Provided that beetroot extract supplement enhanced cardiovascular 
and autonomic recovery after effort, this study advocates that this intervention could be 
considered for reducing cardiovascular complications immediately after exercise. This 
consequence is promising especially, for individuals considering to engage in physical 
activity, but recommended under medical supervision. This study proposes that each 
person should consult with a clinician to verify any contraindications. 
 
CONCLUSION 
Our results indicated that beetroot extract before strength exercise improves SBP 
and HR autonomic recovery after physical effort. This outcome supports the beneficial 
effects of beetroot extract before effort and provides preliminary evidence that beetroot 
extract acutely reduces the likelihood of cardiovascular problems after strength exercises.  
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Table 1: Mean values followed by their respective standard deviations, minimum and 
maximum of age, mass, height, BMI and fat percentage. 
 
Variables Values 
Age (years) 22.33+3.31 (18-23) 
BMI (kg/m²) 23.83+2.58 (20.24-28.37) 
Height (m) 1.75+0.44 (1.65-1.80) 
Mass (kg) 71.62+6.81 (61.4-82) 
Body Fat (%) 10.5+1.5 (8.4-13.3) 

























Figure 1: Flow chart CONSORT diagram. 
Assessed for eligibility (n=16) 
Excluded (n= 3) 
   Not meeting inclusion criteria (high 
body fat) (n=2) 
   Declined to participate (n=1) 
 
Analysed (n=6) 
 Excluded from analysis (n=0) 
Cross-over to beetroot extract (n=7) 
 Received allocated intervention (n=6) 
 Discontinued intervention 
(poor quality R-R intervals) (n=1) 
Allocated to placebo (n=7) 
 Received allocated intervention (n=7) 
 Did not receive allocated intervention 
(poor quality R-R intervals) (n=1) 
Cross-over to placebo (n=6) 
 Received allocated intervention (n=6) 
 Discontinued intervention (n=0) 
Allocated to beetroot extract (n=6) 
 Received allocated intervention (n=6) 
 Did not receive allocated intervention 
(n=0) 
Analysed (n=6) 













Figure 3: Mean values and respective standard deviations of SBP (A), DBP (B) and HR (C) 
obtained at rest and during recovery from strength exercise protocol. *P: Values with significant 
differences in relation to rest (p <0.05) for placebo protocol; *B: Values with significant 
differences in relation to rest (p <0.05) for beetroot extract protocol. SBP: systolic blood 
pressure; DBP: diastolic blood pressure; HR: heart rate;; mmHg: millimeters of mercury; bpm: 





Figure 4: Mean values and respective standard deviations of SDNN (A), RMSSD (B) and 
pNN50 (C) obtained at rest and during recovery from strength exercise protocol. *P: Values with 
significant differences in relation to rest (p <0.05) for placebo protocol; *B: Values with 
significant differences in relation to rest (p <0.05) for beetroot extract protocol. SDNN: standard 
deviation of all normal IBI; RMSSD: square root of the square mean of the differences between 
adjacent normal IBI; pNN50: percentage of adjacent IBI with a difference of duration greater 




Figure 5: Mean values and respective standard deviations of SD1 (A), SD2 (B) and HF (C) 
obtained at rest and during recovery from strength exercise protocol. *P: Values with significant 
differences in relation to rest (p <0.05) for placebo protocol; *B: Values with significant 
differences in relation to rest (p <0.05) for beetroot extract protocol. HF: high frequency; SD1: 
standard deviation of instantaneous beat-to-beat variability; SD2: standard deviation of long 
beat-to-beat variability; ms: milliseconds; ms²: absolute units.  
 
 
 
 
 
 
 
 
